Technical Resources International, Inc. (TRI) has been awarded the Clinical Studies Network (CSN) Clinical Trial Planning and Execution (CTPE) Contract in support of the Biomedical Advanced Research and Development Authority (BARDA), which is part of the U.S. Department of Health and Human Services (HHS) Office of the Assistant Sec
|
BETHESDA, Md., Dec. 16, 2020 /PRNewswire/ -- Technical Resources International Inc.. (TRI) has been awarded the Clinical Studies Network (CSN) Clinical Trial Planning and Execution (CTPE) Contract in support of the Biomedical Advanced Research and Development Authority (BARDA), which is part of the U.S. Department of Health and Human Services (HHS) Office of the Assistant Secretary for Preparedness and Response (ASPR) under contract number 75A50120D00018.
TRI provides clinical trial planning and execution services to clinically evaluate medical countermeasures for diagnosing, treating, and preventing emerging infectious disease (EID), pandemic influenza (PI), and chemical, biological, radiological, and nuclear (CBRN) threats. This involves Phase 1–4 interventional or observational studies. TRI delivers two methods of support: (1) routine (preparedness) studies with non-expedited timelines; and (2) response (emergency) studies in urgent situations with expedited timelines, with a potential scale for local, national, or international emergencies. The main objective of the partnership is to advance the development of lifesaving medical countermeasures (MCMs) by efficiently enabling rigorous clinical trials to assess safety and efficacy of drugs, devices, and biological products. The CSN CTPE contract aims to establish routine CTPE services without expedited timelines, as well as rapid response for CTPE services in urgent situations with expedited timelines during emergencies. About TRI
SOURCE Technical Resources International, Inc. |
View original content to download multimedia:
